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Abstract
To determine the sensitivity and specificity of the 50-g 1-h glucose screening test (GST) for hyperglycemia established in a home- 
monitored glucose profile (H G P ) from blood sampled 1 h after each of the main meals on the following day, we prospectively 
studied 415 pregnant women at increased risk for gestational diabetes and compared 1 G S T  with 1 H G P . At the commonly recom­
mended G S T  threshold of 7.8 mmol/1 and an H G P  threshold of 7.0 mmol/1, the sensitivity of the G S T  was 27%, the specificity 
89%, and the likelihood ratio for a positive test 2.4. Therefore, we conclude that the 50-g 1-h glucose screening test discriminates 
poorly between pregnant women with and without postprandial hyperglycemia.
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1. Introduction
Gestational diabetes mellitus ( G D M )  is defined as 
carbohydrate intolerance recognized during pregnancy 
[1]. The diagnosis of G D M  is generally based on an 
abnormal oral glucose tolerance test ( O G T T )  [2]. The 
whole blood glucose level determined 1 h after a 50-g 
oral glucose load (G S T )  is widely used to detect carbo­
hydrate intolerance [1] and is considered the best screen­
ing test for gestational diabetes mellitus in pregnant 
wom en [2].
Causal treatment of carbohydrate intolerance in preg­
nancy is not yet possible. The aim of therapeutic efforts 
is to avoid hyperglycemia, which is associated with fetal 
morbidity. For that reason, it seems logical to screen 
and monitor blood glucose levels in pregnant wom en 
during nutrition based on their preferences, rather than 
to determine carbohydrate intolerance defined by an ab­
normal reaction to a glucose load.
In an attempt to determine the extent to which the 50­
g 1-h glucose screening test can be used as a screening
* Corresponding author.
test for the occurrence of hyperglycemia in a home- 
monitored glucose profile (H G P )  on a normal diet, we 
compared the results of the G S T  and the H G P .
2. Subjects and methods
From July 1989 to July 1991 we prospectively studied 
415 pregnant wom en considered to be at risk for gesta­
tional diabetes mellitus ( G D M ) .  Each w om an  had one 
or more of the following risk factors: a past history of 
G D M ,  a previous macrosomic or hypoglycemic infant, 
a positive family history, age 35 years or more, obesity, 
recurrent glucosuria, or accelerated fetal growth in the 
present pregnancy. Patients with known type 1 or type 
2 diabetes mellitus, and wom en with multiple pregnancy 
were excluded.
In all subjects a 50-g 1-h G S T  was performed after the 
20th week of gestation. Capillary blood was sampled 1 
h after intake of the 50-g oral glucose load, without 
prior glucose loading or fasting. O n  the same day the 
wom en were instructed by a nurse to take their own 
capillary blood samples at home. Samples for the H G P  
were collected on the following day in prelabeled
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fluoride oxalate tubes, 1 h after breakfast, lunch, and 
dinner. All glucose levels were determined in the labora­
tory the next day in whole blood using the hexokinase 
method (Boehringer-Mannheim). One  G S T  and one 
H G P  were obtained from each subject and used for 
comparison.
In wom en in w hom  both the G S T  and the maximal 
H G P  value did not exceed 7.0 mol/1, glucose concentra­
tions were considered normal and were not further 
tested. Patients in w hom  both the G S T  and the maximal 
H G P  concentration exceeded the value of 7.0 mmol/1 
were treated with dietary measures alone or in combina­
tion with insulin, if necessary to maintain postprandial 
glucose values at or below 7.0 mmol/1. W h e n  either the 
G S T  or the maximal H G P  value was above 7.0 mmol/1, 
but the other was not, a second home glucose profile 
(H G P 2 )  was performed. Patients in this group were 
treated only if the H G P 2  value exceeded 7.0 mmol/1. In 
this subgroup of 94 patients we compared the maximal 
glucose concentration of the first H G P  with that of 
H G P 2 .
Differences in relative frequencies between groups 
were tested by x 2 test, relationships between variables 
were tested by linear regression analysis. A  P  value 
< 0 .05  was considered significant. The study was ap­
proved by the University and Hospital Ethics C o m ­
mittee.
3. Results
The gestational age at the time of testing ranged from 
20 to 35 weeks, with a median of 24 weeks. Thirty-seven 
(9 % ) of the 415 wom en had a glucose value that exceed­
ed 7.0 mmol/1 in the H G P .  At the generally recommend­
ed G S T  threshold of 7.8 mmol/1 [2] and an H G P  
threshold of 7.0 mmol/1, both the G S T  and the H G P  did 
not exceed the threshold in 336 w om en, both were above 
the threshold in 10 wom en, and in 69 wom en the results 
of one of the tests were above the threshold value. At 
these thresholds, the sensitivity of the G S T  was 2 7 % , the 
specificity 8 9% , the likelihood ratio for a positive test 2.4 
and that for a negative test 0.8. Although the G S T  cor­
relates significantly with the H G P  (P  <  0.05), Fig. 1 
shows that the correlation is poor (r -  0.37).
Fig. 2 demonstrates the effect of changing the G S T  
threshold —  in the absence of a change in H G P  thres­
hold —  on sensitivity, specificity, and the likelihood 
ratios of a positive and a negative test.
Fig. 3 demonstrates the absence of a significant corre­
lation (P  >  0.05, r =  0.32) between the maximal values 
of the first and second H G P ,  as determined in the 94 
women in w hom  either the G S T  or the maximal value of 
the first H G P  exceeded 7.0 mmol/1. The sensitivity of the 
first H G P  for H G P 2  was 2 6 % , the specificity 8 4% , the 
likelihood for a positive test 1.6 and that for a negative 
test 0.9.
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Fig. 1. The blood glucose value 1 h after a 50-g glucose load (GST) 
plotted against the maximal postprandial glucose value obtained in the 
home-monitored glucose profile (HGP), shows poor correlation 
(r = 0.37). n = 415.
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Fig. 2. The sensitivity, specificity and likelihood ratios o f the 50-g 1-h 
glucose screening test for the occurrence of postprandial hyperglyce­
mia in the home-monitored glucose profile were calculated at varying 
GST thresholds.
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Fig. 3. The maximal postprandial glucose value obtained in one home 
glucose profile (1) plotted against that obtained on another day (2), 
shows poor correlation (r = 0.32). n = 94. .
4. Discussion
It is assumed that hyperglycemia during pregnancy is 
harmful to the fetus and newborn, because it increases 
the incidence of macrosomia, birth trauma, hyper­
bilirubinemia, hypocalcemia and polycythemia [2]. 
Therefore, considerable effort is put into the detection 
and treatment of G D M .
Gestational diabetes mellitus is defined as carbohydr­
ate intolerance with onset or recognition during preg­
nancy [1]. The diagnosis is usually based on an 
abnormal 2- or 3-h 50- or 100-g O G T T  in the fasting 
state following several days of high carbohydrate diet. If 
the O G T T  is abnormal the patient is treated with a diet 
containing complex carbohydrates and avoiding 
monosaccharides, to which insulin is added if necessary 
to maintain normoglycemia. Apart from the differences 
resulting from the various ways in which the O G T T  is
performed, it has been demonstrated that the 
reproducibility of the O G T T  is low (78% ) [3] and that 
the 50-g O G T T  overestimates the occurrence of hyper­
glycemia by 2 8 %  [4], For those reasons an abnormal 
O G T T  does not necessarily mean that glucose values 
under the less unphysiologic circumstances of a diet 
based on w om en ’s preferences are abnormal. Therefore, 
we chose hyperglycemia occurring in the H G P  on a nor­
mal diet as the diagnostic endpoint in our study.
The disadvantage of using H G P  as an endpoint is that 
it indicates the glycemic control at the time of the test, 
while hyperglycemia as a result of carbohydrate in­
tolerance may not yet be apparent and may become 
manifest later in pregnancy. This implies that testing 
should be repeated later in pregnancy.
Determination of a plasma glucose level 1 h after a 50­
g oral glucose challenge is generally considered to be the 
best screening test for detection of gestational diabetes 
mellitus [2]. Ninety-six percent of materal-fetal special­
ists of the American College of Obstetricians and 
Gynecologists use this method [1], which may be per­
formed in either the fasting or the fed state [5]. In 
screening tests a high sensitivity is preferred over a high 
specificity. A  threshold no higher than 140 mg/dl, or 7.8 
mmol/1, has been recommended for the G S T  to obtain 
a high sensitivity in universal screening programs [2], At 
the threshold of 7.8 mmol/1 we found that the G S T  fail­
ed to predict hyperglycemia in 21 of 37 wom en, so that 
the sensitivity for hyperglycemia was only 27% .
The optimal threshold of a test is determined not only 
by the values of sensitivity and specificity, but also by 
the prevalence of the condition in the population under 
study. W h e n  sensitivity and specificity are known, 
Bayes’s theorem allows the calculation of predictive 
values for a given prevalence. Given 2 7 %  sensitivity, 
8 9 %  specificity, and an assumed 5 %  prevalence of hy­
perglycemia during pregnancy in the general popula­
tion, the positive and negative predictive values of the 
G S T  at the commonly used threshold of 7.8 mmol/1 
would be 1 1 %  and 9 6% , respectively. For a high-risk 
population with 5 0 %  prevalence, the positive and nega­
tive predictive values at the same threshold would
Table 1
Fetal outcome related to glucose test results
Greater than 90th 
percentile infant
Instrumental
delivery
5'-Apgar 
score <  7
Perinatal
deaths
n n % n % n % n %
GST normal, HGP normal 302 25 (8) 52 (17) 7 (2) 3 (1)
GST normal, HGP abnormal 18 1 (6) 4 (22) 0 (0) 0 (0)
GST abnormal, HGP normal 76 6 (8) 14 (18) 2 (3) 0 (0)
GST abnormal, HGP abnormal 19 3 (16) 4 (21) 0 (0) 0 (0)
Total 415 35 (8) 74 (18) 9 (2) 3 (1)
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change to 7 1 %  and 5 5 % , respectively. This indicates that 
the G S T  at the commonly used threshold is a poor 
predictor of hyperglycemia in the pregnant population 
at large, and is far from optimal in a group of wom en 
at high risk for gestational diabetes. By increasing the 
threshold, the sensitivity decreases and the specificity in­
creases, the probability of a positive test increases, and 
that of a negative test decreases. A s  illustrated by Fig. 
2, it is impossible to identify a G S T  threshold that will 
provide a clinically meaningful discrimination between 
wom en with and without hyperglycemia.
A s  shown in Fig. 3, the reproducibility of the H G P  is 
poor. Apparently neither a single G S T  nor a single H G P  
is a reliable indicator of hyperglycemia in wom en at risk 
for gestational diabetes. If one assumes that the G S T  
and H G P  are independent tests and that the prior odds 
for hyperglycemia in our study population was 0.1, the 
posterior odds of a positive G S T  and H G P  can be 
calculated as 0.1/0.9 x  2.4 x  1.6 =  0.43. This increases 
the probability of hyperglycemia only threefold, to 30% . 
After a negative G S T  and H G P ,  the posterior odds are 
5.76, which implies a probability of 8 5 %  that hypergly­
cemia is indeed absent. Therefore, we must conclude 
that our current policy results in many false positives 
and false negatives.
Given the methodological shortcomings in the identi­
fication of wom en with hyperglycemia, the question 
should be asked how  effective our efforts really are in 
terms of costs and perinatal outcome. The answer to this 
question requires a randomized controlled study in 
which pregnant wom en, tested for hyperglycemia, are 
randomly assigned to a treatment and a control group. 
Until the data of such a study are known, we can either 
continue to fool ourselves, give dietary advice to all 
pregnant wom en without further testing, or abstain 
from testing as well as from dietary prescriptions.
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